Filing Details
- Accession Number:
- 0001209191-23-027361
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-05-04 16:38:07
- Reporting Period:
- 2023-04-12
- Accepted Time:
- 2023-05-04 16:38:07
- Original Submission Date:
- 2023-04-14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1820187 | D Marlan Walker | 951 Yamato Road Suite 220 Boca Raton FL 33431 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-04-26 | 1,010 | $0.00 | 14,041 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-04-26 | 1,734 | $0.00 | 12,307 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-04-26 | 692 | $3.64 | 11,615 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2023-04-26 | 1,010 | $0.00 | 1,010 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2023-04-26 | 1,734 | $0.00 | 1,734 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
3,466 | No | 4 | M | Direct |
Footnotes
- The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.
- The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.
- Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.